Pain Measurement in Rheumatic and Musculoskeletal Diseases

Where To Go from Here? Report from a Special Interest Group at OMERACT 2018

Alessandro Chiarotto*, Ulrike Kaiser, Ernest Choy, Robin Christensen, Philip G Conaghan, Mary Cowern, Michael Gill, Maarten de Wit, Elizabeth Gargon, Ben Horgan, Jamie J Kirkham, Lee S Simon, Jasvinder A Singh, Peter Tugwell, Dennis C Turk, Philip J Mease

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

OBJECTIVE: Establishing a research agenda on standardizing pain measurement in clinical trials in rheumatic and musculoskeletal diseases (RMD).

METHODS: Discussion during a meeting at the Outcome Measures in Rheumatology (OMERACT) 2018, prepared by a systematic review of existing core outcome sets and a patient online survey.

RESULTS: Several key questions were debated: Is pain a symptom or a disease? Are pain core (sub)domains consistent across RMD? How to account for pain mechanistic descriptors (e.g., central sensitization) in pain measurement?

CONCLUSION: Characterizing and assessing the spectrum of pain experience across RMD in a standardized fashion is the objective of the OMERACT Pain Working Group.

Original languageEnglish
JournalJournal of Rheumatology
Volume46
Issue number10
Pages (from-to)1355-1359
ISSN0315-162X
DOIs
Publication statusPublished - Oct 2019

Fingerprint

Musculoskeletal Diseases
Public Opinion
Pain Measurement
Rheumatic Diseases
Central Nervous System Sensitization
Rheumatology
Outcome Assessment (Health Care)
Clinical Trials
Research

Keywords

  • Measurement
  • Musculoskeletal health
  • OMERACT
  • Pain
  • Rheumatology

Cite this

Chiarotto, Alessandro ; Kaiser, Ulrike ; Choy, Ernest ; Christensen, Robin ; Conaghan, Philip G ; Cowern, Mary ; Gill, Michael ; de Wit, Maarten ; Gargon, Elizabeth ; Horgan, Ben ; Kirkham, Jamie J ; Simon, Lee S ; Singh, Jasvinder A ; Tugwell, Peter ; Turk, Dennis C ; Mease, Philip J. / Pain Measurement in Rheumatic and Musculoskeletal Diseases : Where To Go from Here? Report from a Special Interest Group at OMERACT 2018. In: Journal of Rheumatology. 2019 ; Vol. 46, No. 10. pp. 1355-1359.
@article{84497c6fe0a24bfc9a157dd3a1eed8cb,
title = "Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018",
abstract = "OBJECTIVE: Establishing a research agenda on standardizing pain measurement in clinical trials in rheumatic and musculoskeletal diseases (RMD).METHODS: Discussion during a meeting at the Outcome Measures in Rheumatology (OMERACT) 2018, prepared by a systematic review of existing core outcome sets and a patient online survey.RESULTS: Several key questions were debated: Is pain a symptom or a disease? Are pain core (sub)domains consistent across RMD? How to account for pain mechanistic descriptors (e.g., central sensitization) in pain measurement?CONCLUSION: Characterizing and assessing the spectrum of pain experience across RMD in a standardized fashion is the objective of the OMERACT Pain Working Group.",
keywords = "Measurement, Musculoskeletal health, OMERACT, Pain, Rheumatology",
author = "Alessandro Chiarotto and Ulrike Kaiser and Ernest Choy and Robin Christensen and Conaghan, {Philip G} and Mary Cowern and Michael Gill and {de Wit}, Maarten and Elizabeth Gargon and Ben Horgan and Kirkham, {Jamie J} and Simon, {Lee S} and Singh, {Jasvinder A} and Peter Tugwell and Turk, {Dennis C} and Mease, {Philip J}",
year = "2019",
month = "10",
doi = "10.3899/jrheum.181099",
language = "English",
volume = "46",
pages = "1355--1359",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology Publishing Co. Ltd.",
number = "10",

}

Chiarotto, A, Kaiser, U, Choy, E, Christensen, R, Conaghan, PG, Cowern, M, Gill, M, de Wit, M, Gargon, E, Horgan, B, Kirkham, JJ, Simon, LS, Singh, JA, Tugwell, P, Turk, DC & Mease, PJ 2019, 'Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018', Journal of Rheumatology, vol. 46, no. 10, pp. 1355-1359. https://doi.org/10.3899/jrheum.181099

Pain Measurement in Rheumatic and Musculoskeletal Diseases : Where To Go from Here? Report from a Special Interest Group at OMERACT 2018. / Chiarotto, Alessandro; Kaiser, Ulrike; Choy, Ernest; Christensen, Robin; Conaghan, Philip G; Cowern, Mary; Gill, Michael; de Wit, Maarten; Gargon, Elizabeth; Horgan, Ben; Kirkham, Jamie J; Simon, Lee S; Singh, Jasvinder A; Tugwell, Peter; Turk, Dennis C; Mease, Philip J.

In: Journal of Rheumatology, Vol. 46, No. 10, 10.2019, p. 1355-1359.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Pain Measurement in Rheumatic and Musculoskeletal Diseases

T2 - Where To Go from Here? Report from a Special Interest Group at OMERACT 2018

AU - Chiarotto, Alessandro

AU - Kaiser, Ulrike

AU - Choy, Ernest

AU - Christensen, Robin

AU - Conaghan, Philip G

AU - Cowern, Mary

AU - Gill, Michael

AU - de Wit, Maarten

AU - Gargon, Elizabeth

AU - Horgan, Ben

AU - Kirkham, Jamie J

AU - Simon, Lee S

AU - Singh, Jasvinder A

AU - Tugwell, Peter

AU - Turk, Dennis C

AU - Mease, Philip J

PY - 2019/10

Y1 - 2019/10

N2 - OBJECTIVE: Establishing a research agenda on standardizing pain measurement in clinical trials in rheumatic and musculoskeletal diseases (RMD).METHODS: Discussion during a meeting at the Outcome Measures in Rheumatology (OMERACT) 2018, prepared by a systematic review of existing core outcome sets and a patient online survey.RESULTS: Several key questions were debated: Is pain a symptom or a disease? Are pain core (sub)domains consistent across RMD? How to account for pain mechanistic descriptors (e.g., central sensitization) in pain measurement?CONCLUSION: Characterizing and assessing the spectrum of pain experience across RMD in a standardized fashion is the objective of the OMERACT Pain Working Group.

AB - OBJECTIVE: Establishing a research agenda on standardizing pain measurement in clinical trials in rheumatic and musculoskeletal diseases (RMD).METHODS: Discussion during a meeting at the Outcome Measures in Rheumatology (OMERACT) 2018, prepared by a systematic review of existing core outcome sets and a patient online survey.RESULTS: Several key questions were debated: Is pain a symptom or a disease? Are pain core (sub)domains consistent across RMD? How to account for pain mechanistic descriptors (e.g., central sensitization) in pain measurement?CONCLUSION: Characterizing and assessing the spectrum of pain experience across RMD in a standardized fashion is the objective of the OMERACT Pain Working Group.

KW - Measurement

KW - Musculoskeletal health

KW - OMERACT

KW - Pain

KW - Rheumatology

U2 - 10.3899/jrheum.181099

DO - 10.3899/jrheum.181099

M3 - Journal article

VL - 46

SP - 1355

EP - 1359

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 10

ER -